The mission of the institute is to translate basic genetic and molecular mechanisms of schizophrenia and related developmental brain disorders into clinical advances that change the lives of affected individuals. It is catalyzing a new understanding of brain disease by linking advances in the construction and function of the human brain with the development of novel therapeutic strategies.
In care of Andrew Maslan
Donations are tax-deductible
Category
Other
Employees
152
Volunteers
9
Financial Snapshot
FY ending 2023-06-30
Revenue
$28.9M
Expenses
$31.4M
Assets
$36.7M
Liabilities
$12.7M
Financial history
$31.4M$15.7M$0
1617181920212223
RevenueExpenses
Latest FY2023: $28.9M · Avg: $20.3M
Foreign activity (Schedule F)
Total spent abroad$0
Foreign employees0
Foreign offices0
Foreign partnership interestNo
Foreign trust interestNo
Region
Activity
Spent
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM
—
—
501(h) election
This 501(c)(3) has NOT elected 501(h) — lobbying is permitted but limited under the vaguer "no substantial part of activities" test.